RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Syreeta Tilghman to Mitogen-Activated Protein Kinases

Back to Details
This is a "connection" page, showing publications Syreeta Tilghman has written about Mitogen-Activated Protein Kinases.
Syreeta Tilghman
Connection Strength
0.219
Mitogen-Activated Protein Kinases
  1. Patel JR, Banjara B, Ohemeng A, Davidson AM, Bou? SM, Burow ME, Tilghman SL. Novel Therapeutic Combination Targets the Growth of Letrozole-Resistant Breast Cancer through Decreased Cyclin B1. Nutrients. 2023 Mar 28; 15(7).
    View in: PubMed
    Score: 0.219
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support